Measuring harm and informing quality improvement in the Welsh NHS: the longitudinal Welsh national adverse events study by Mayor, Sharon et al.
Measuring harm and informing quality
improvement in the Welsh NHS:
the longitudinal Welsh national
adverse events study
Sharon Mayor,1* Elizabeth Baines,2 Charles Vincent,3
Annette Lankshear,4 Adrian Edwards,1
Mansel Aylward,5 Helen Hogan,6 Paul Harper,7
Jan Davies,8 Ameet Mamtora,9 Emily Brockbank10
and Jonathon Gray11,12
1Division of Population Medicine, Cardiff University, Cardiff, UK
2Quality and Safety, NHS Wales Delivery Unit, Pencoed, UK
3Department of Psychology, University of Oxford, Oxford, UK
4School of Healthcare Sciences, Cardiff University, Cardiff, UK
5Public Health Wales, Cardiff, UK
6Department of Health Services Research and Policy, London School of Hygiene
and Tropical Medicine, London, UK
7School of Mathematics, Cardiff University, Cardiff, UK
8Quality and Safety, Welsh Government, Cardiff, UK
9Cardiff and Vale University Health Board, Cardiff, UK
10Aneurin Bevan University Health Board, Newport, UK
11Centre for Healthcare Improvement and Innovation, Counties Manukau District
Health Board, Auckland, New Zealand
12Healthcare Improvement and Innovation, Victoria University of Wellington,
Wellington, New Zealand
*Corresponding author
Declared competing interests of authors: Charles Vincent reports personal fees from Cardiff University
during the conduct of the study, personal fees from the Swiss Federal Office of Health, personal fees from
haélò, personal fees from Wiley-Blackwell, personal fees from Healthcare at Home and grants from The
Health Foundation outside the submitted work. Jonathon Gray reports other from Counties Manukau





Measuring harm in Welsh NHS hospitals
Health Services and Delivery Research 2017; Vol. 5: No. 9
DOI: 10.3310/hsdr05090
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Scientific summary
Background and aims
Despite global activity over the past 15 years to improve patient safety, the measurement of adverse event
(AE) rates remains challenging. Although many approaches have been used, and are in use, the dual-stage
retrospective review of medical records has been the methodology of choice in large-scale studies. The first
stage involves the completion of criterion-referenced screening review form 1 (RF1), which is undertaken by
nurses or experienced clinical governance facilitators, and the second, undertaken by doctors, is completion
of the modular review form 2 (MRF2). The Global Trigger Tool (GTT), developed by the US Institute for
Healthcare Improvement, is another widely used retrospective review of medical records, which uses a
time-limited pragmatic approach. This tool requires the random selection and limited case note review of
20 inpatient records per month per organisation. At the commencement of this study in 2011, Welsh health
boards had experience in using this tool, but its implementation was not regulated and commitment to the
methodology and the outcomes generated was highly variable across the Welsh health boards.
Study aims and objectives
This study aimed to obtain definitive longitudinal data on harm in NHS Wales hospitals and to compare the
performance of the GTT with the two-stage retrospective review process using findings to improve an
approach to ongoing surveillance of harm in the Welsh NHS.
The specific aims over the course of the project were as follows:
1. to gain an in-depth understanding of the nature and number of AEs occurring in the Welsh population
admitted to hospital over a 4-year period (2011–15), comparing the use of the retrospective two-stage
process and GTT reviews
2. to compare the scale and scope of health-care-related harm identified by the retrospective two-stage
process and GTT reviews
3. to develop a robust ongoing measurement system for harm
4. to embed this harm surveillance in organisations and to determine the organisational response.
Methods
The study was undertaken in two discrete data generation phases separated by a transition period to
undertake interim analysis informing phase 1. The second phase was followed by a final process evaluation
examining the impact of the study and its output data on the NHS health board recipients. The study
sample comprised two acute hospital sites from each of the six Welsh health boards. A sample size of
5000 records was calculated based on the incidence of harm found in previous studies.
Phase 1
In phase 1, we undertook a two-stage retrospective review of 20 adult patients per month with an inpatient
stay of > 24 hours who had been identified using a random system generator and whose notes had
been pulled for routine GTT review by health board staff. The study team then undertook a two-stage
retrospective review process. We added a harm determination phase at the end of the nurse screening
process and asked the nurses to rate their confidence in their decision on a 1–5 scale. Positive notes from
phase 1 were sent for a second-stage review by research physicians, who used the MRF2 to judge the
occurrence, nature, preventability and consequences of the referred event.
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Analysis of phase 1 data using Stata version 14 (StataCorp LP, College Station, TX, USA) followed the
conventional GTT method in which the aggregated data are converted into a harm rate and then compared
with a baseline. We used the same methodology to compare aggregate rates in the two methodologies. An
unweighted kappa coefficient was used to assess inter-rater reliability with corresponding 95% confidence
interval (CI) and the percentage of records that were concordant or discordant.
Transition phase
During the transition phase, a number of factors influenced the planning and execution of phase 2, including:
l the decision of NHS Wales to cease use of the GTT
l a mandate in Wales that every inpatient death must be assessed by review of the inpatient episode of
care, currently using the seven questions of the Universal Mortality Review (UMR) tool
l the need of the NHS for an operationally manageable tool using a one-step process.
On the basis of phase 1 data, we identified the criteria that were the most sensitive and specific markers
of AEs in current use and, furthermore, refined others to identify acts of omission to improve both the
identification of a wide range of events and the face validity of the tool with a range of health-care
professionals. The new screening criteria were included in a new tool, the Harm2 tool, which was developed
for the routine surveillance of AEs in practice. The Harm2 tool is a hybrid of the one-stage GTT process and
a condensed RF1 and MRF2 screening and measurement structure. We then trained a team of research
nurses in using the Harm2 tool to undertake medical record assessment across study sites.
Phase 2
The monthly sample of reviewed notes included 20 random discharges and 10 admissions of patients who
died from each study site using explicit case note selection criteria. During the analysis we assessed both
intermethod (RF1/MRF2 vs. Harm2) and inter-rater reliability.
We determined the percentage of patients experiencing an AE and the severity and level of preventability
of the incident. Univariate logistic regression assessed the relationship between demographic and chronic
disease states and the subsequent development of AEs. Descriptive statistics were used to describe
and compare the nature and severity of AEs in the random and deceased patient cohorts. We tested the
Harm2 tool against the two-stage process (intermethod reliability), and an unweighted kappa coefficient
was used to assess inter-rater reliability.
Service evaluation and impact assessment
From a constructivist perspective and using semistructured interviews, we explored the review process with
the RF1 reviewers and, from the perspective of key NHS informants, the value and use of the data by
health boards. Interview data were anonymised and thematically analysed. When available, documentary
evidence was used to confirm the narrative.
Findings
Phase 1
In total, 4536 episodes of care from 11 of the 12 invited hospitals were reviewed, with the number of
samples from individual hospitals ranging from 174 to 560. The mean age of patients was 64.1 years
(95% CI 63.48 to 64.66 years). A total of 1430 (32.6%) inpatient episodes of care had at least one
identified positive screening criterion for potential AEs (with a range seen across individual organisations of
between 23% and 43%) and, of these, 821 inpatient episodes (18.1%) were referred for in-depth physician
review and 790 were completed across the study sites (96.2%). At least one AE was determined in 10.3%
of all episodes of care (95% CI 9.4% to 11.2%). In total, 73.1% of patients with AEs needed additional
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treatment and/or days in hospital, 16% were discharged with a significant impairment to their functional
status and in 9% of cases the AE may have been associated in some way with the patient dying during the
inpatient episode. Physician assessment of problems in care in the referred sample revealed that failure
in clinical monitoring and management was identified in one-third of all events. Failure to manage and
prevent infection (29%), problems with an operation or procedure (21%) and problems in the prescribing,
administration or monitoring of drugs and fluids (18.7%) were identified as common problems in care.
We also found the following.
l There was a statistically significant increase in positive criteria with increasing age up to 85 years.
l The percentage of harm identified by non-physicians was 10.4%, which was comparable with that
determined by physicians, of 10.3%.
l Although there is a high level of agreement on harm identified in the professional groups, differences
in the type of events identified are recognised.
l There was a statistically significant association between mean length of hospital stay and risk of
experiencing an AE (p < 0.0001).
l The mean rate of AEs using the GTT methodology, across NHS Wales, was lower than the rate
reported through the two-stage retrospective review process (mean 9.0%, 95% CI 8.82% to 9.18%).
l We could profile the risk of AEs in individual organisations by producing signatures of harm for each
NHS site.
As part of the process of quality assuring the data generated from the RF1 reviews, we began to see
distinct patterns of harm emerging from individual organisations. We tested these patterns with site leads
by ranking the top five frequently occurring criteria that were linked to AEs for each organisation and
presenting these as their ‘organisational signatures’ of harm. Assessment of signatures of harm along with
the AE rate allows for (1) examination of how big an individual issue is within a health-care system, (2) the
triangulation of harm data with other organisational data such as incident reports, (3) a mechanism for
awareness raising around specific organisational issues or interventions and (4) a potential mechanism for
quality improvement evaluation.
Phase 2
Twelve NHS organisations participated in this phase between May 2014 and September 2015, during
which time we reviewed 4396 records from randomly selected discharges (n = 3352) and randomly
selected deceased discharges (n = 1044) samples. In the randomly selected discharges sample, at least one
AE requiring intervention or subsequent readmission was determined in 11.3% of all episodes of care
(95% CI 10.22% to 12.40%) and 59.6% of AEs were deemed to be preventable (95% CI 55.29% to
63.91%). In the deceased sample, at least one AE was determined in 315 (30.1%) episodes of care
studied (95% CI 28.13% to 33.8%2) and 61.7% of AEs identified were deemed to be preventable
(95% CI 57.49% to 65.91%).
Patient factors associated with AEs in the randomly selected discharges sample included being aged over
85 years and having peripheral vascular disease (PVD), hemiplegia or dementia. No association with
chronic disease was identified in the deceased group, but AEs occurred twice as frequently in emergency
admissions and were associated with increased length of stay.
In the 10% of the Harm2 tool records that were double reviewed, there was agreement in 336 out of
380 cases (88.4%; κ = 0.50, 95% CI 0.38 to 0.65). In 422 Harm2 reviews, the RF1 was also completed
and physicians using the MRF2 reviewed 74 inpatient episodes. Agreement on the presence of AEs was
evident in 58 out of 74 reviews or 78.4% (κ = 0.45, 95% CI 0.07 to 0.62), indicating a moderate level
of agreement.
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Service evaluation phase
We interviewed a total of 27 individuals including 14 reviewers (of whom 12 were from nursing or
midwifery backgrounds) and 13 members of health boards (of whom seven were medical directors or
assistant medical directors).
The review process
After training, reviewers found the Harm2 criteria clear and the tool easy to use, and monthly conference
calls enhanced reliability.
Factors that facilitated reviewing included the following:
l collaborative or unified notes, which made it easier to ensure that concerns and prescribed actions
were addressed
l live data, including discharge letters entered on the Welsh Clinical Portal (NHS Wales Informatics
Service), that were legible and could be accessed remotely.
Factors that challenged the review process included:
l poor-quality notes, especially those of deceased patients
l notes that had been digitised, as poor scanning, lack of searchability and automatic timeouts all
contributed to difficulties
l partly electronic and partly paper records, with separate records held by therapists
l a focus on a single episode of acute care, which prevented comment on the holistic care of people
with long-term mental illnesses admitted to an acute facility.
The management and usefulness of the data in health boards
Independent review was thought to be useful because it was resourced and offered freedom from
acculturation. However, it divorced learning from clinical practice. Owing to the small numbers of notes
reviewed monthly at the health board level, the usefulness of the data was perceived as limited in the early
months, although this increased as the numbers built up. The single page of output data was thought to
be excellent but not easily digested, and was thus considered too complex for widespread dissemination.
The key value of the data lay in the ability to compare harm rates in the randomly selected discharges
sample and randomly selected deceased discharges samples, as there was a suspicion that the study’s
mortality review process, similar to the UMR, was picking up features of the dying process rather than
harm per se. The harm signature presented to health boards contained no surprises, but was useful in
validating existing findings from Datix® (Datix, London, UK) and existing clinical dashboards.
Conclusions
The rate of harm detected across NHS Wales, using both the two-stage retrospective review process and
the new Harm2 tool, conforms to that found by previous studies conducted in both the UK and Europe.
Chronic disease is not strongly associated with the risk of incurring AEs or complications and data do not
need to be collected routinely on the presence of all comorbid conditions for improvement purposes.
With training and using a structured review process, non-physician reviewers undertake case note review
efficiently and effectively, and rates of AEs, preventability and breakdown of problems in care conform to
studies in which physicians undertake these classifications. The determination of preventability is, however,
challenging for reviewers. In 78% of cases there is agreement between professional groups on the
determination of harm events. There are, however, differences in the events identified.
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The Harm2 tool performed with moderate reliability in the determination of AEs, although screening
criteria can be further refined. The rate and composition of AEs are influenced by both the balance of
cases selected from different specialties and whether the patient died or was discharged alive.
A pragmatic approach with a robust measurement structure offers the potential for routine screening of
AEs in NHS organisations. However, stability in case note review teams is highly valued to ensure reliability
and highlight local learning.
Although chronic disease is not strongly associated with the risk of incurring AEs or complications,
older patients with pre-existing diagnoses of dementia, PVD and hemiplegia appear to be at greater risk
of AEs, probably as a result of underlying functional and cognitive impairment. Our data suggest that
organisational quality improvement efforts to improve the safety of the ward environment may reduce the
levels of AEs in these groups.
The difficulties encountered by our reviewers in navigating and finding information, in both paper and
digitised case notes, suggest that similar difficulties may be encountered in clinical practice.
It would be relatively straightforward to devise a means of continuing the current approach by sampling
across the country on a regular basis and undertaking comparative work with incident reporting systems,
but in the longer term we need to set measures of harm alongside measures of the beneficial effects of
health care first at the level of populations and, then, more ambitiously, for individual patients.
Funding
Funding for this study was provided by the Health Services and Delivery Research programme of the
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